Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation for Liver Malignancy at High-risk ;Locations

王健,佟小强,吕天石,宋莉,吕永兴,邹英华

DOI: https://doi.org/10.3969/j.issn.1009-6604.2016.01.003

2016-01-01

Abstract:Objective To evaluate the safety and effectiveness of the combined therapy with transcatheter arterial chemoembolization ( TACE) and radiofrequency ablation ( RFA) for liver malignancy at high-risk locations. Methods Between June 2009 and January 2014, fifty-two patients with liver malignancy at high-risk locations (including 43 cases of primary liver cancer and 9 cases of hepatic metastases) were enrolled in the study. All the patients received TACE and followed with RFA performed under the guidance of ultrasonography plus CT scanning (50 cases) or X-ray fluoroscopy (2 cases). The follow-up period was 12 months. Safety effectiveness was evaluated by observation of the relevant complications during or directly after RFA procedure, and also at 1 week, 1-month, 3-month, 6-month and 12-month after RFA. Complete ablation was defined as no viable sign of residual tumor confirmed by enhanced CT or MRI after 12-month’ s follow-up. Effectiveness of TACE+RFA was evaluated by complete ablation rate at the end of follow-up time. Results All the 52 patients underwent successful TACE + RFA. There were no significant complications observed after the procedure or during the follow-up period. By the end of the follow-up at 12-month postoperation, all the patients survived. The tumor had been completely abalted in 49 cases (94. 2%). Incomplete ablation with residual tumor signs was detected by enhanced MRI or CT in 3 ( 5. 8%) of the 52 cases, which was given continoues TACE treatment. Conclusions TACE combined with RFA is a safe and effective therapy for liver malignancy at high-risk locations. Moreover, precise image guidance with X-ray, ultrasonography and CT and experiences and skills of operators are quite important for a successful RFA at high-risk locations.